Application of the Mexican Sequential Organ Failure Assessment Score to Critically Ill Cancer Patients

CHEST Journal ◽  
2015 ◽  
Vol 148 (4) ◽  
pp. 346A
Author(s):  
Silvio Ñamendys-Silva ◽  
Yves Jarquín-Badiola ◽  
Francisco Garcia-Guillen ◽  
Mireya Barragan-Dessavre ◽  
Andoreni Bautista-Ocampo ◽  
...  
Keyword(s):  
Sequential Organ Failure Assessment ◽  
Organ Failure ◽  
Cancer Patients ◽  
Critically Ill ◽  
Assessment Score ◽  
Failure Assessment

SERIAL EVALUATION OF THE SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE TO PREDICT OUTCOME IN CRITICALLY ILL PATIENTS.

2006 ◽  
Vol 34 ◽  
pp. A142
Author(s):  
Margarida Câmara ◽  
Ofélia Afonso ◽  
António Táboas ◽  
J L Brandão ◽  
Álvaro Silva ◽  
...  
Keyword(s):  
Sequential Organ Failure Assessment ◽  
Organ Failure ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Assessment Score ◽  
Failure Assessment ◽  
Serial Evaluation

Prognostic performance of pancreatic stone protein in critically ill patients with sepsis

2019 ◽  
Vol 13 (17) ◽  
pp. 1469-1480
Author(s):  
Luis García de Guadiana-Romualdo ◽  
María Dolores Albaladejo-Otón ◽  
Mario Berger ◽  
Enrique Jiménez-Santos ◽  
Roberto Jiménez-Sánchez ◽  
...  
Keyword(s):  
Sequential Organ Failure Assessment ◽  
Organ Failure ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Operating Characteristic ◽  
Pancreatic Stone ◽  
Assessment Score ◽  
Unit Management ◽  
Failure Assessment ◽  
Intensive Care Unit Management

Aim: To assess the prognostic value for 28-day mortality of PSP in critically ill patients with sepsis. Material & methods: 122 consecutive patients with sepsis were enrolled in this study. Blood samples were collected on admission and day 2. Results: On admission, the combination of PSP and lactate achieved an area under the receiver operating characteristic (AUC-ROC) of 0.796, similar to sequential organ failure assessment score alone (AUC-ROC: 0.826). On day 2, PSP was the biomarker with the highest performance (AUC-ROC: 0.844), although lower (p = 0.041) than sequential organ failure assessment score (AUC-ROC: 0.923). Conclusion: The combination of PSP and lactate and PSP alone, on day 2, have a good performance for prognosis of 28-day mortality and could help to identify patients who may benefit most from tailored intensive care unit management.

Sign in / Sign up

Export Citation Format

Share Document